Uncovering Institutional Buying In Structure Therapeutics Inc ADR (NASDAQ: GPCR)
T. Rowe Price Associates, Inc. recently announced the acquisition of new stake in Structure Therapeutics Inc ADR (NASDAQ:GPCR). The institutional investor has increased its shareholding in the Healthcare company by 41.74% to 2.51 million shares with purchase of 0.74 million shares. This fresh investment now brings its stake to 5.42% valued currently at $139.98 million. […]
